Tea planter Vishal Mahindra was twice diagnosed with non-Hodgkin's lymphoma, a type of blood cancer that develops in the ...
Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin ... B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy ...
So why do we have it if it makes the condition worse? Well, the scientists think that though the reaction may worsen the rash itself, it could also offer an immune response to certain bacteria.
Constantly scratching and picking at an itchy rash really does make it worse. But why? According to newly released research using mice as a model, scratching aggravates inflammation and swelling ...
Hundreds of people have reported stolen phones during the first two weeks of Montreal’s annual Igloofest. Toronto resident Mikaila Donald, 20, is one of thousands who flocked to the outdoor ...
In response, the body prioritizes central blood volume by reducing circulation to the skin, which can result in a purple-red rash appearing on the cheeks and the bridge of the nose. Shaped ...
Parents are heartbroken as a beloved nappy rash cream - Metanium Nappy Rash Ointment - is discontinued. The product, known for its quick healing properties, has been a staple in changing bags for ...
The rising trend in health and lifestyle related problems in the world warrants us to be well informed and health-conscious of the latest happenings in this field. Medindia offers a freely ...
Truman Capote's "In Cold Blood" documented the killings of a family of four in rural Kansas on this day in 1959 Eli Wizevich A new book by historian William E. Leuchtenburg examines how the first ...
2-Year U.S. Treasury Note Continuous Contract $102.754-0.059-0.06% 5-Year U.S. Treasury Note Continuous Contract $106.430 0.039 0.04% 10-Year U.S. Treasury Note Continuous Contract $109.031 0.188 ...
Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was turned down by the FDA in the US. Join the conversation, on Tuesday ...